https://aclarion.com/aclarion-inc-announces-listing-on-nasdaq-and-pricing-of-9-4-million-initial-public-offering/2023-02-15T15:28:28-08:00https://aclarion.com/aclarion-inc-announces-closing-of-9-4-million-initial-public-offering/2023-02-15T15:28:13-08:00https://aclarion.com/aclarion-to-present-2-year-follow-up-data-linking-nociscan-to-better-surgical-outcomes/2023-02-15T15:27:50-08:00https://aclarion.com/aclarion-announces-start-of-healthcare-economic-analysis-study-to-evaluate-financial-impact-of-nociscan/2023-02-15T15:27:29-08:00https://aclarion.com/nociscan-selected-for-inclusion-in-pivotal-national-institutes-of-health-nih-study-for-low-back-pain/2023-02-15T15:27:12-08:00https://aclarion.com/john-keller-m-d-to-join-aclarion-as-a-key-opinion-leader-surgeon-advisor/2023-02-15T15:26:57-08:00https://aclarion.com/aclarion-announces-participation-at-the-nass-37th-annual-meeting/2023-02-15T15:26:28-08:00https://aclarion.com/aclarion-to-present-at-the-ld-micro-main-event-xv/2023-02-15T15:26:00-08:00https://aclarion.com/dr-sigurd-berven-to-join-aclarion-as-a-key-opinion-leader-surgeon-advisor/2023-02-15T15:25:38-08:00https://aclarion.com/aclarion-adds-to-strong-patent-portfolio-with-notice-of-allowance-for-new-u-s-patent-application-addressing-key-pain-indicator-biomarker/2023-02-15T15:25:16-08:00https://aclarion.com/aclarion-adds-to-growing-key-opinion-leader-program-with-juan-uribe-m-d-as-a-surgeon-advisor/2022-12-19T06:06:58-08:00https://aclarion.com/aclarions-key-opinion-leader-program-adds-fifth-surgeon-advisor-with-addition-of-eric-potts-md/2023-02-15T15:24:41-08:00https://aclarion.com/dr-christopher-ames-to-join-aclarion-as-a-key-opinion-leader-surgeon-advisor/2023-02-15T15:24:26-08:00https://aclarion.com/aclarions-executive-director-featured-in-wall-street-transcript-article/2023-02-15T15:24:02-08:00https://aclarion.com/aclarion-appoints-george-frey-md-as-seventh-key-opinion-leader-surgeon-advisor/2023-02-15T15:23:50-08:00https://aclarion.com/gregory-basil-md-to-join-aclarion-as-a-key-opinion-leader-surgeon-advisor/2023-02-15T15:23:34-08:00https://aclarion.com/aclarion-supports-thought-leadership-at-the-2nd-annual-sonntag-spine-symposium/2023-02-15T15:23:18-08:00https://aclarion.com/aclarion-announces-alpesh-patel-md-mba-as-a-key-opinion-leader-physician-advisor/2023-03-09T05:40:49-08:00https://aclarion.com/aclarion-announces-publication-of-2yr-outcomes-in-groundbreaking-clinical-trial/2023-04-26T14:34:02-07:00https://aclarion.com/aclarion-appoints-nicholas-theodore-md-as-principal-investigator-for-clarity-post-market-trial-evaluating-nociscan-in-the-diagnosis-and-treatment-of-chronic-low-back-pain/2023-05-03T06:36:26-07:00https://aclarion.com/aclarions-key-opinion-leader-program-adds-ninth-surgeon-advisor-with-addition-of-dean-karahalios-md/2023-05-23T08:29:26-07:00https://aclarion.com/aclarion-announces-new-engagement-with-the-london-clinic-and-london-spine-clinic/2023-05-30T15:21:38-07:00https://aclarion.com/aclarion-announces-statistically-significant-nociscan-cost-effectiveness-abstract-presented-at-isass-annual-meeting/2023-06-08T06:29:46-07:00https://aclarion.com/aclarion-announces-new-commercial-engagement-with-the-imaging-center-grand-rapids-mi/2023-06-14T08:34:36-07:00https://aclarion.com/aclarion-announces-signing-strategic-partnership-letter-of-intent-with-atec-to-advance-commercialization-of-nociscan/2023-10-23T09:01:02-07:00https://aclarion.com/aclarion-announces-nociscan-cost-effectiveness-poster-presented-at-45th-annual-smdm-meeting/2023-10-24T12:39:39-07:00https://aclarion.com/aclarion-announces-signing-of-commercial-agreement-with-porter-hospital-an-adventhealth-facility-to-bring-nociscan-technology-to-denver/2023-10-25T05:45:21-07:00https://aclarion.com/aclarion-presents-at-the-nih-heal-initiative-fall-meeting/2023-11-02T16:05:07-07:00https://aclarion.com/aclarion-expands-immediate-nociscan-access-into-new-york-city-with-tenth-key-opinion-leader-surgeon-advisor-addition-roger-hartl-md/2023-11-09T10:16:12-08:00https://aclarion.com/aclarion-announces-achievement-of-goal-to-enroll-10-leading-spine-surgery-key-opinion-leaders-kols-to-support-nociscan-adoption/2023-11-10T13:23:57-08:00https://aclarion.com/aclarion-announces-key-commercial-milestone-with-completion-of-1000-nociscan-exams/2023-11-27T05:59:20-08:00https://aclarion.com/aclarion-and-atec-execute-strategic-partnership-agreement-to-advance-commercialization-of-nociscan/2024-01-08T07:14:51-08:00https://aclarion.com/aclarion-expands-nociscan-access-into-phoenix-with-key-opinion-leader-surgeon-advisor-juan-uribe-md/2024-01-22T08:06:47-08:00https://aclarion.com/publication-of-compelling-peer-reviewed-data-in-international-journal-of-spine-surgery-supporting-nociscan-as-a-gold-standard-for-noninvasive-identification-of-painful-lumbar-discs/2024-04-02T10:11:31-07:00https://aclarion.com/nociscan-solution-to-play-key-role-in-groundbreaking-lifehab-trial/2024-04-25T09:35:49-07:00https://aclarion.com/aclarion-announces-updated-product-release-that-enhances-user-experience-scalability-and-security-for-nociscan-solution/2024-06-18T07:16:28-07:00https://aclarion.com/aclarion-receives-notice-of-allowance-for-us-patent-to-support-further-optimization-of-accuracy-and-reliability-in-the-nociscan-solution/2024-06-20T08:23:56-07:00https://aclarion.com/aclarion-expands-commercial-engagement-with-the-london-clinic-to-grow-access-to-nociscan-throughout-greater-london/2024-06-25T05:40:42-07:00https://aclarion.com/aclarion-hits-another-key-milestone-with-second-payer-coverage-of-nociscan-by-aviva-throughout-uk/2024-07-09T09:01:38-07:00https://aclarion.com/aclarion-hits-another-key-milestone-by-adding-third-major-payer-in-greater-uk/2024-08-13T06:32:25-07:00https://aclarion.com/aclarion-announces-first-commercial-agreement-in-michigan/2024-08-14T06:28:54-07:00https://aclarion.com/aclarion-launches-the-clinical-utility-and-economic-clue-trial/2024-08-21T07:08:46-07:00https://aclarion.com/aclarion-launches-second-clinical-utility-and-economic-clue-trial-site-with-first-surgeon-in-new-jersey/2024-08-29T11:29:03-07:00https://aclarion.com/aclarion-launches-surgeon-partnership-in-personal-injury-and-workers-compensation-market/2024-09-05T08:01:48-07:00https://aclarion.com/aclarion-announces-completion-of-first-nociscan-exams-in-lifehab-trial/2024-09-10T06:34:46-07:00https://aclarion.com/aclarion-provides-corporate-update-on-nociscan-ai-technology-milestones/2024-09-12T09:06:22-07:00https://aclarion.com/aclarions-nociscan-ai-plays-key-role-in-advanced-understanding-of-modic-changes/2024-09-27T06:46:30-07:00https://aclarion.com/aclarion-announces-initial-payer-coverage-of-nociscan-by-axa-throughout-greater-london-uk/2024-06-26T06:41:33-07:00https://aclarion.com/aclarion-announces-nociscan-featured-in-rsna-edition-of-siemens-magnetom-flash/2024-11-22T06:30:02-08:00https://aclarion.com/aclarion-to-showcase-groundbreaking-nociscan-technology-at-the-selby-spine-conference/2025-01-31T12:12:46-08:00https://aclarion.com/aclarion-announces-clarity-trial-for-nociscan-now-fully-funded/2025-02-04T06:05:59-08:00https://aclarion.com/aclarion-announces-northwestern-medicine-as-first-clarity-trial-site/2025-02-06T06:16:22-08:00https://aclarion.com/aclarion-receives-us-patent-to-protect-expanded-applications-of-magnetic-resonance-spectroscopy-mrs-data-processing-to-identify-pain-and-infection-biomarkers-throughout-the-body/2025-02-11T06:23:15-08:00https://aclarion.com/aclarion-to-showcase-groundbreaking-nociscan-technology-at-the-2025-spine-summit/2025-02-20T06:21:26-08:00https://aclarion.com/aclarion-announces-first-commercial-agreement-with-scripps-health/2025-03-03T06:16:06-08:00https://aclarion.com/aclarion-announces-expansion-plans-with-radnet-affiliates-in-new-york-and-new-jersey/2025-03-06T07:18:13-08:00https://aclarion.com/aclarion-announces-expansion-to-santa-monica-with-medical-imaging-center-of-southern-california/2025-04-02T06:08:42-07:00https://aclarion.com/aclarion-announces-publication-of-seminal-nociscan-cost-effectiveness-analysis/2025-04-21T06:23:02-07:00https://aclarion.com/aclarion-announces-commercial-agreement-with-spine-institute-of-louisiana/2025-04-29T06:02:16-07:00https://aclarion.com/aclarion-welcomes-advocate-health-as-clarity-trial-site/2025-05-05T06:20:31-07:00https://aclarion.com/aclarion-announces-texas-back-institute-as-new-clarity-trial-site/2025-05-12T06:26:44-07:00https://aclarion.com/aclarion-announces-addition-of-keck-medical-center-of-usc-as-clarity-trial-site/2025-05-20T06:13:43-07:00https://aclarion.com/aclarion-adds-uhealth-university-of-miami-miller-school-of-medicine-as-clarity-trial-site/2025-06-10T06:12:14-07:00https://aclarion.com/aclarion-to-present-nociscan-technology-at-leading-spine-innovation-forum/2025-06-24T06:12:03-07:00https://aclarion.com/first-patient-enrolled-in-aclarions-groundbreaking-clarity-trial/2025-06-25T06:08:50-07:00https://aclarion.com/aclarion-provides-corporate-update-highlighting-scan-volume-growth-and-key-upcoming-catalysts/2025-08-05T06:36:38-07:00https://aclarion.com/aclarion-appoints-greg-gould-as-chief-financial-officer/2025-09-03T06:32:56-07:00https://aclarion.com/first-patients-enrolled-at-uhealth-university-of-miami-in-aclarions-pivotal-clarity-trial/2025-09-25T06:18:44-07:00https://aclarion.com/aclarion-honored-as-finalist-for-the-2025-digital-health-hub-foundation-digital-health-awards-at-hlth/2025-10-07T06:32:18-07:00https://aclarion.com/aclarion-announces-use-of-mr-spectroscopy-for-identifying-biomarkers-of-discogenic-pain-highlighted-at-global-neuroscience-conference/2025-10-13T06:26:28-07:00https://aclarion.com/aclarion-provides-corporate-update-highlighting-market-expansion-as-clarity-trial-advances-toward-key-data-catalyst/2025-10-14T05:53:00-07:00https://aclarion.com/aclarion-wins-rising-star-at-2025-digital-health-hub-foundation-digital-health-awards-at-hlth/2025-10-22T09:40:16-07:00https://aclarion.com/aclarion-appoints-dan-isherwood-as-uk-commercial-director-to-drive-adoption-and-market-expansion/2025-11-05T06:47:43-08:00https://aclarion.com/medical-device-news-magazine/2025-11-05T16:43:18-08:00https://aclarion.com/beckers-spine-review-2/2025-11-05T16:43:41-08:00https://aclarion.com/big-biz-show/2025-11-05T16:45:55-08:00https://aclarion.com/alpha-wolf-capital/2025-11-05T16:46:16-08:00https://aclarion.com/orthopedics-this-week/2025-11-05T16:47:43-08:00https://aclarion.com/779-2/2025-11-25T08:05:21-08:00https://aclarion.com/aclarion-appoints-jason-brosniak-as-commercial-director-to-drive-adoption-and-market-expansion-in-the-eastern-u-s/2025-12-02T06:22:02-08:00https://aclarion.com/aclarion-announces-publication-of-nociscan-article-in-special-pain-issue-of-the-international-journal-of-spine-surgery-ijss/2025-12-04T06:29:19-08:00https://aclarion.com/aclarion-announces-first-patient-enrollments-at-two-additional-clarity-trial-sites-and-provides-guidance-on-expected-availability-of-initial-data/2026-01-06T06:11:30-08:00https://aclarion.com/aclarion-provides-2025-update-and-2026-corporate-outlook/2026-01-08T06:14:13-08:00https://aclarion.com/aclarion-strengthens-balance-sheet-and-extends-cash-runway-into-2028/2026-01-13T06:29:08-08:00https://aclarion.com/aclarion-adds-high-volume-practice-source-healthcare-to-support-nociscan-growth-and-real-world-evidence-generation/2026-02-03T06:20:36-08:00https://aclarion.com/aclarion-publishes-2026-shareholder-letter-from-the-chairman/2026-02-05T06:31:00-08:00https://aclarion.com/aclarion-publishes-ceo-shareholder-letter-highlighting-strategic-progress-and-2026-catalysts/2026-03-19T06:09:30-07:00https://aclarion.com/stocktwits/2026-04-02T14:30:12-07:00https://aclarion.com/empowered-patient-podcast/2026-04-02T14:31:43-07:00https://aclarion.com/medical-design-outsourcing/2026-04-02T14:32:11-07:00https://aclarion.com/ceocfo-magazine/2026-04-02T14:31:20-07:00https://aclarion.com/orthopedic-design-technology/2026-04-02T14:32:29-07:00https://aclarion.com/the-wall-street-transcript/2026-04-02T14:31:04-07:00https://aclarion.com/sports-medicine-broadcast/2026-04-02T14:30:33-07:00https://aclarion.com/aclarion-highlights-growing-adoption-of-nociscan-at-the-london-clinic-with-new-physician-video/2026-04-07T06:40:14-07:00https://aclarion.com/aclarion-announces-agreement-with-weill-cornell-medicine/2026-04-08T06:20:21-07:00https://aclarion.com/aclarion-secures-u-s-patent-advancing-scalable-ai-driven-assessment-of-chronic-low-back-pain/2026-04-16T06:12:32-07:00https://aclarion.com/aclarion-announces-2-5-million-stock-repurchase-plan/2026-04-22T06:13:45-07:00https://aclarion.com/aclarion-appoints-daniel-keefe-as-commercial-director-western-u-s-to-drive-continued-adoption-of-nociscan/2026-04-28T04:49:54-07:00https://aclarion.com/aclarion-delivers-strong-q1-2026-results-with-196-annual-scan-volume-growth-reflecting-accelerating-clinical-adoption/2026-04-30T06:00:20-07:00https://aclarion.com/planet-microcap/2026-05-04T17:59:18-07:00https://aclarion.com/aclarion-announces-second-commercial-agreement-with-weill-cornell-medicine/2026-05-05T05:48:39-07:00https://aclarion.com/aclarion-announces-addition-of-first-private-practice-site-in-los-angeles-into-clarity-trial-to-further-accelerate-enrollment/2026-05-07T06:03:59-07:00https://aclarion.com/aclarion-technology-demonstrates-potential-beyond-surgical-planning-in-new-immune-biomarker-study/2026-06-01T06:23:48-07:00https://aclarion.com/aclarion-adds-institute-of-neuro-innovation-to-support-nociscan-growth-and-real-world-evidence-generation/2026-06-03T06:14:16-07:00https://aclarion.com/aclarion-partners-with-pria-healthcare-to-advance-reimbursement-and-commercial-adoption-of-its-ai-powered-nociscan-platform/2026-06-09T06:25:04-07:00https://aclarion.com/aclarion-announces-texas-spine-care-center-as-new-clarity-site/2026-07-07T06:28:18-07:00https://aclarion.com/aclarion-announces-presentation-of-two-abstracts-highlighting-nociscans-growing-role-in-real-world-clinical-practice/2026-07-21T06:26:25-07:00https://aclarion.com/aclarion-publishes-ceo-shareholder-letter-highlighting-progress-for-first-half-of-2026/2026-07-29T06:26:27-07:00https://aclarion.com/first-half-2026-letter-to-shareholders/2026-07-29T06:28:22-07:00https://aclarion.com/aclarion-announces-nociscan-now-available-at-goodman-campbell-brain-spine-at-ascension-st-vincent-first-site-in-indiana-to-offer-the-technology/2026-08-10T15:07:56-07:00https://aclarion.com/aclarion-receives-notice-of-allowance-for-patent-advancing-accuracy-and-adoption-of-nociscans-mr-spectroscopy-mrs-scan-process/2026-08-12T06:20:17-07:00